V116 (PCV21) was more cost-effective than PCV20 alone and PCV15 plus PPSV23 for the prevention of adult pneumococcal disease.
In Spain, Grau et al. reported a 67% reduction in VT-IPD among 4011 HIV-infected adults receiving care at a teaching hospital in Barcelona 6 years after vaccine introduction.
Serological response to vaccination—defined as a titre ... identifying those who have been diagnosed with invasive pneumococcal disease to assess further efficacy although this presents with ...
In significant efforts to strengthen public health and improve vaccine access in Africa, the U.S. International Development Finance Corporation, the African Development Bank, and the International ...
collectively known as Invasive Pneumococcal Disease (IPD). Vaccination can protect against some of these infections and can prevent complications in children, it adds. For more news like this ...
New partnership aims to accelerate vaccine development and manufacturing for priority pathogens that disproportionately impact Africa Aligns with Africa’s regional vaccine manufacturing agenda ...
Pfizer’s latest-generation pneumococcal conjugate vaccine is in line to reach more people in Latin America and the Caribbean ...
Pfizer PFE is a key player in the PCV vaccine space. PFE markets Prevnar 20, which is approved for the prevention of IPD caused by 20 serotypes in individuals aged six weeks and older. PFE also ...
DAKAR, SENEGAL / ACCESSWIRE / December 13, 2024 / IAVI, a nonprofit scientific research organization dedicated to addressing urgent global health challenges including HIV, tuberculosis, and ...
While studies have evaluated pneumonia, VT-NP carriage and VT-IPD, the demonstration of indirect ... [4] we anticipate that with time and more study, vaccination of infants using all of these ...